Brain growth in babies linked to amount of time and energy mothers ‘invest’

Brain growth in babies is linked to the amount of time and energy mothers ‘invest’, according to new research published today. The study of 128 mammal species, including humans, shows that brain growth in babies is determined by the duration of pregnancy and how long they suckle. The Durham University research concludes that the longer […]
Continue reading…

 

Cancer drug Gleevec may hold promise against scleroderma: Study

A drug approved to treat certain types of cancer has shown promising results in the treatment of patients with scleroderma, according to results from an open-label Phase II trial. While the drug’s efficacy must be demonstrated in a Phase III trial, the gold standard for testing a drug, researchers are optimistic that Gleevec- (imatinib) could […]
Continue reading…

 

Plasmid containing Sindbis replicase genes can destruct lung cancer

Alpha viruses, such as Sindbis virus, carry their genetic information on a single strand of RNA. On infection they use a protein, replicase, to produce double stranded RNA (dsRNA) which is used as genetic material to make more viruses. However the body recognizes dsRNA as foreign, and infected cells initiate an immune response. New research […]
Continue reading…

 

FDA approves ipilimumab to treat metastatic melanoma

The US Food and Drug Administration announced today that the drug ipilimumab (brand name Yervoy) has been approved for the treatment of patients with metastatic melanoma. It is the first drug ever shown to improve overall survival for patients with advanced melanoma. Ipilimumab uses a novel approach known as immunotherapy, which exploits the body’s own […]
Continue reading…

 

First open fetal surgery to treat lung malformations performed at Texas Children’s Hospital

Experts from Texas Children’s Fetal Center published a study that appears in volume 46, issue 2 of the Journal of Pediatric Surgery documenting the first successful cases of open fetal surgery to treat fetal lung malformations in the Southern U.S. The study also provides improved data to diagnose, assess, predict risk, and recommend treatment for […]
Continue reading…

 

Researchers discover LRRK2 gene mutation may cause Parkinson’s disease

Researchers at Mount Sinai School of Medicine have discovered a way that mutations in a gene called LRRK2 may cause the most common inherited form of Parkinson’s disease. The study, published online this month in the journal Public Library of Science, shows that upon specific modification called phosphorylation, LRRK2 protein binds to a family of […]
Continue reading…

 

HCG hormone therapy may benefit patients with intractable pain

Results from a small study of intractable pain patients being treated with the human chorionic gonadotropin (HCG) hormone reported that they had experienced pain free hours in the past month. These results were presented today at a poster session at the American Academy of Pain Medicine’s 27th Annual Meeting. Forest Tennant M.D., Ph.D., of the […]
Continue reading…

 

Novel Immunotherapy Drug Receives FDA Approval For The Treatment Of Metastatic Melanoma

The US Food and Drug Administration announced that the drug ipilimumab (brand name Yervoy) has been approved for the treatment of patients with metastatic melanoma. It is the first drug ever shown to improve overall survival for patients with advanced melanoma. Ipilimumab uses a novel approach known as immunotherapy, which exploits the body’s own immune […]
Continue reading…

 

Study develops new approaches for sorting out complexities of cancer cells

New drugs that specifically target the mutated genes responsible for cancer growth have shown great success in extending the lives of patients, with far fewer side effects than conventional anti-cancer therapies. Unfortunately, many patients become resistant to these drugs due to secondary mutations. Now, a multidisciplinary team of researchers at UCLA has developed a “roadmap” […]
Continue reading…

 

High Altitude Boosts Longevity And Reduces Risk Of Dying Of Ischemic Heart Disease

In one of the most comprehensive studies of its kind, researchers at the University of Colorado School of Medicine in partnership with the Harvard School of Global Health have found that people living at higher altitudes have a lower chance of dying from ischemic heart disease and tend to live longer than others. “If living […]
Continue reading…

 

Stem Cell Research May Lead To New Treatments For Parkinson’s Disease, Huntington’s Disease, Multiple Sclerosis, Stroke, Spinal Cord Injury

A group of scientists at Marshall University is conducting research that may someday lead to new treatments for repair of the central nervous system. Dr. Elmer M. Price, who heads the research team and is chairman of Marshall’s Department of Biological Sciences, said his group has identified and analyzed unique adult animal stem cells that […]
Continue reading…

 

FDA Approves New Treatment For A Type Of Late-stage Skin Cancer

The U.S. Food and Drug Administration today approved Yervoy (ipilimumab) to treat patients with late-stage (metastatic) melanoma, the most dangerous type of skin cancer. Melanoma is the leading cause of death from skin disease. An estimated 68,130 new cases of melanoma were diagnosed in the United States during 2010 and about 8,700 people died from […]
Continue reading…